dfwhockeyguy

CNAT

Largo
NASDAQ:CNAT   None
Disclaimer: All biotechs are extremely risky, so do your own DD


I like this setup in CNAT. Despite the fact CNAT has recently failed a trial, I look at this as an opportunity to run before the next dataset in the 1st half of 2019.


Reasons I believe this is:

Stock has a history of filling all gaps in the chart. Gap at 4.50 currently needs to be filled.
Ascending Triangle Chart Pattern (bullish)
Even though it temporarily made historically new lows for the stock, it subsequently rebounded off the long term support area.

Risks are as follows:

Stock offerings (although they already raised 28.6 million for trials and expenses back in May)
Failed trial


We'll see how it plays out

Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.